Follow The Filings

OCSL Oaktree Specialty Lending

Oaktree Specialty Lending earnings company data as of 4:49 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 17 Nov EPS 0.34 — —
Rev — — —

Insider trades

Open-market buys and sales by OCSL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OCSL insider trades
  • $70K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Armen Panossian See Remarks
    Buy
    $22K 1,700 shares at $12.69 +8.2% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  2. Phyllis R Caldwell Director
    Buy
    $27K 2,500 shares at $10.77 +12% to stake
    Traded Mar 16 Filed Mar 18
    ↗
  3. Deborah Ann Gero Director
    Buy
    $22K 2,000 shares at $10.78 +8.9% to stake
    Traded Mar 16 Filed Mar 18
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
424B2 Filing Doc
8-K 1.01,9.01 Filing Doc
424B2 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.02,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.